Regulatory authorities require more and more clinical data. Protocols are increasingly complex, and the challenges of recruiting patients and qualified investigators continue to grow. In this climate, early and careful evaluation of protocol and recruitment plans can help avoid costly missteps. Our information-driven approach to Site and Patient Access uses unique patient insight data from multiple providers, including medical claims, EMR, social listening and performance data in unique “delivery prescriptions” for each clinical project. When coupled with our Catalyst Site delivery models, this can result in predictable and efficient project delivery.
About Site and Patient Access
Supporting site and patient stakeholders is a key focus of our business strategy. Our reputation with clinical research sites is invaluable to us. And we are committed to our status as the “CRO of Choice” for the site community, as proven by being ranked as the top CRO amongst the top 10 global CROs in the 2017 CentreWatch survey and 2017 SCRS Eagle award winners.
